FACULTY
Chaitu S. Malempati, MD, FAAOS
Smith & Nephew Orthopaedics : Paid consultant for a company/supplier; Research support from company/supplier
Aravind Athiviraham, MD, FRCS(C)
Arthrex, Inc : Speakers bureau/honorarium payment; Paid consultant for a company/supplier
Armando F. Vidal, MD
Stryker Endoscopy: Royalties from a company/supplier; Paid consultant for a company/supplier; Unpaid consultant for
company/supplier
Arthrex, Inc : Research support from company/supplier
David L. Bernholt, MD
Gentlemen Orthopedic Solutions (Arthrex Distributor) : Other support from a company/supplier
Shana Miskovsky, MD
Arthrex, Inc. : Other support from acompany/supplier
Seth L. Sherman, MD
ConMed Linvatec : Royalties from a company/supplier; Speakers bureau/honorarium payment
DJO : Royalties from a company/supplier
Arthrex, Inc. : Paid consultant for a company/supplier
LifeNet : Paid consultant for a company/supplier
Vericel : Paid consultant for a company/supplier
BioEnthesis Inc. : Stock options in a company/supplier
Epicrispr BioTech : Stock options in a company/supplier
Icarus Bracing : Stock options in a company/supplier
Kyniska Robotics : Stock options in a company/supplier
Moximed: Stock options in a company/supplier
Reparel : Stock options in a company/supplier
Sarcio Inc : Stock options in a company/supplier
Sparta Biomedical : Stock options in a company/supplier
Vivorte : Stock options in a company/supplier
AlloSource : Research support from company/supplier
JRF : Research support from company/supplier
Smith & Nephew : Research support from company/supplier
Kinamed : Research support from company/supplier
Octane Biotherapeutics : Research support from company/supplier
Miach Orthopaedics Inc : Research support from company/supplier
Ossio : Research support from company/supplier
U Pitt : Research support from company/supplier
PLANNERS
Ashley Meyer
Nothing to disclose
Christina Ortega
Nothing to Disclose
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.
ORIGINAL RELEASE DATE: 2/28/2025
TERMINATION DATE: 2/27/2028